Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Preventing hospitalizations for respiratory syncytial virus infection

2015; Oxford University Press; Volume: 20; Issue: 6 Linguagem: Inglês

10.1093/pch/20.6.321

ISSN

1918-1485

Autores

Joan Robinson, Nicole Le Saux,

Tópico(s)

Viral gastroenteritis research and epidemiology

Resumo

Respiratory syncytial virus infection is the leading cause of lower respiratory tract infections in young children. Palivizumab has minimal impact on RSV hospitilization rates as it is only practical to offer it to the highest risk groups. The present statement reviews the published literature and provides updated recommendations regarding palivizumab use in children in Canada.

Referência(s)